- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16.01. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 29.12.25 | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 17.12.25 | IMAC Holdings, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 16.12.25 | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 01.12.25 | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| IMAC HOLDINGS Aktie jetzt für 0€ handeln | |||||
| 20.11.25 | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 14.11.25 | IMAC Holdings, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | - | SEC Filings | ||
| 31.10.25 | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 03.10.25 | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 18.09.25 | IMAC Holdings, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 10.09.25 | IMAC Holdings, Inc.: Ignite Proteomics Announces Collaboration with Inova Health on a Biomarker Study for Late-Stage Cancers | 140 | GlobeNewswire (Europe) | The First Precision Oncology Trial to Use a Functional Proteomics and Phosphoproteomics Assay for Treatment Decision Making in a Pan-Tumor Study Golden, CO, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Ignite... ► Artikel lesen | |
| 10.09.25 | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.08.25 | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 05.08.25 | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 28.01.25 | Pre-market Movers: IMAC Holdings, Planet Image International, SAB Biotherapeutics, MicroCloud Hologram, Avalon Holdings | 914 | AFX News | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.30 A.M. ET).In the Green IMAC Holdings, Inc. (BACK) is up over 91% at $1.59.
Planet... ► Artikel lesen | |
| 27.01.25 | IMAC Holdings, Inc.: IMAC Holdings Introduces Ignite Proteomics: A New Standard for Matching Patients with the Right Cancer Therapies | 261 | GlobeNewswire (Europe) | Nashville, TN, Jan. 27, 2025 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) ("IMAC Holdings" or the "Company") has launched Ignite Proteomics LLC ("Ignite"), its new subsidiary dedicated to... ► Artikel lesen |
16 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 0,256 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics Provides Business Update on REYOBIQ Clinical Program and U.S. CNSide Commercialization | HOUSTON, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ: PSTV) (the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| LIFEWARD | 0,650 | -3,07 % | Oramed Pharmaceuticals Inc.: Oramed and Lifeward Announce Strategic Transaction | Transaction Will Transfer Oramed's Oral Drug Delivery Platform (POD Technology) to Lifeward and Positions Oramed as a Significant Shareholder
Oramed will transfer... ► Artikel lesen | |
| EKSO BIONICS | 7,950 | -8,73 % | EKSO BIONICS HOLDINGS, INC. - 8-K, Current Report | ||
| IMUNON | 3,060 | -1,29 % | Imunon, Inc.: IMUNON Reports Third Quarter 2025 Financial Results and Provides Business Update | R&D Day showcased remarkable Investigator optimism, continued strengthening supportive data, and significant progress with Phase 3 OVATION 3 Study in pursuit of first frontline immunotherapy for advanced... ► Artikel lesen | |
| BIOCEPT | 7,200 | 0,00 % | GlaxoSmithKline Bioc: Gewinn im zweiten Quartal bei 5,9 Mio. EGP | ||
| ROCKWELL MEDICAL | 0,983 | +6,62 % | Why Is Rockwell Medical Gaining Tuesday? | ||
| VIRIDIAN THERAPEUTICS | 27,960 | +0,47 % | UBS stuft Viridian Therapeutics mit "Buy" ein - Kursziel impliziert 63 % Potenzial | ||
| SINTX TECHNOLOGIES | 3,460 | -1,42 % | SiNtx Technologies, Inc.: SINTX Technologies unterzeichnet Liefervertrag mit EVONIK zur Herstellung eines Siliziumnitrid-PEEK-Verbundwerkstoffes für KI-gestützte, 3D-gedruckte patientenspezifische Implantate | Ein Meilenstein, der die sofortige Produktion von maßgefertigten SiN/PEEK-Implantaten ermöglichtSALT LAKE CITY, Utah, Dec. 01, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX"... ► Artikel lesen | |
| AETHLON MEDICAL | 3,080 | 0,00 % | AETHLON MEDICAL INC - 8-K, Current Report | ||
| STAGEZERO LIFE SCIENCES | 0,028 | -100,00 % | StageZero Life Sciences Ltd.: StageZero Announces Partial Revocation of Failure to File Cease Trade Order and Proposed Financing | ||
| NEURONETICS | 1,906 | +2,25 % | Neuronetics, Inc. - 8-K, Current Report | ||
| ARCH THERAPEUTICS | - | - | Arch Therapeutics, Inc. - 15-12G, Securities registration termination | ||
| HVIVO | 0,059 | +3,51 % | hVIVO PLC - Notice of Trading Update | ||
| SIEMENS HEALTHINEERS | 43,290 | 0,00 % | BERENBERG stuft Siemens Healthineers auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Siemens Healthineers auf "Buy" mit einem Kursziel von 54 Euro belassen. 2025 sei ein weiteres durchwachsenes Jahr für den... ► Artikel lesen |
IMAC HOLDINGS INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,008 (-4,00 %) liegt der Kurs bei 0,192 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IMAC HOLDINGS INC finden Sie auf Wallstreet Online.